Accès à distance ? S'identifier sur le proxy UCLouvain
Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer
Primary tabs
- Open access
- 479.67 K
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès libre |
Publication date | 2013 |
Language | Anglais |
Journal information | "Clinical Cancer Research" - Vol. 19, no.7, p. 1902-1912 (2013) |
Peer reviewed | yes |
Publisher | American Association for Cancer Research ((United States) Denville, NJ) |
issn | 1078-0432 |
e-issn | 1557-3265 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie UCL - (SLuc) Unité d'oncologie médicale |
MESH Subject | Antibodies, Monoclonal ; Neoplasm Metastasis ; Prognosis ; Receptor, Epidermal Growth Factor ; Treatment Outcome ; Tumor Markers, Biological ; Antineoplastic Agents ; Colorectal Neoplasms ; Genes, ras ; High-Throughput Nucleotide Sequencing ; Humans ; Multilocus Sequence Typing ; Mutation ; Mutation Rate |
Links |
Bibliographic reference | Peeters, Marc ; Oliner, Kelly S ; Parker, Alex ; Siena, Salvatore ; Van Cutsem, Eric ; et. al. Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. In: Clinical Cancer Research, Vol. 19, no.7, p. 1902-1912 (2013) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/156687 |